Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine Iridium III Complexes Through the Switch from Cationic to Zwitterionic Forms
Inorganic Chemistry · 2025
DOI: 10.1021/acs.inorgchem.4c04937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Zhe Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Life-Organic Analysis of Shandong Province, Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges a…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Iridium, Coordination Complexes, Pyrazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, Natural Science Foundation of Shandong Province, Shandong Provincial Colleges and Universities.
Abstract (Originalsprache)
Cyclometalated iridium III complexes have shown promising anticancer properties, with variations in charge and ligand substitution significantly influencing their biological activity. However, zwitterionic iridium III complexes remain scarcely explored. Herein, we report a series of zwitterionic cyclometalated imidazole/pyrazole-imine iridium III complexes and compare their biological activity to analogous cationic complexes with sulfonate counteranions. X-ray crystallography confirmed the structural differences between the cationic and zwitterionic forms. These complexes exhibited cytotoxicity against A549, HeLa, and HepG2 cancer cells, with IC 50 values ranging from 14.35 to 69.12 μM. While cationic complexes showed higher cytotoxicity, zwitterionic complexes demonstrated enhanced selectivity for A549 cancer cells over BEAS-2B normal cells (selectivity index: 3.72–5.90 for zwitterionic forms vs 1.16–1.44 for cationic forms). This selectivity is attributed to distinct cellular uptake mechanisms: zwitterionic complexes use an energy-dependent pathway in cancer cells and an energy-independent pathway in normal cells, leading to differences in cellular accumulation and redox activity. Mechanistic studies revealed that both complex types induce ROS generation and mitochondrial membrane depolarization (MMP), with apoptosis as the primary cell death pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Life-Organic Analysis of Shandong Province, Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges and Universities of Shandong Province, School of Chemistry and Chemical…
Förderung
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
- Shandong Provincial Colleges and Universities
Zitieren
APA
Liu, Z., Lai, K., Li, P., Gong, Y., Fu, H., Dong, H., Yang, Z., Qin, R., & Guo, L. (2025). Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine Iridium III Complexes Through the Switch from Cationic to Zwitterionic Forms. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c04937
Vancouver
Liu Z, Lai K, Li P, Gong Y, Fu H, Dong H, et al. Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine Iridium III Complexes Through the Switch from Cationic to Zwitterionic Forms. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.4c04937
BibTeX
@article{Liu2025,
author = {Liu, Zhe and Lai, Kangning and Li, Pengwei and Gong, Yuwen and Fu, Hanxiu and Dong, Heqian and Yang, Zhihao and Qin, Ruixin and Guo, Lihua},
title = {Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine Iridium III Complexes Through the Switch from Cationic to Zwitterionic Forms},
journal = {Inorganic Chemistry},
year = {2025},
doi = {10.1021/acs.inorgchem.4c04937}
}
EUVIMED